IUPAC Traditional

2-methyl-2-(morpholin-4-yl)-N-[(3R,4S)-4-[(quinolin-4-yl)methyl]oxolan-3-yl]propanamide

Compound number MolPort-046-520-015
Molecular weight 383.492
InChI key XYKZLKGFQDNCDD-XLIONFOSSA-N
Molecular formula C22H29N3O3
DMSO Solubility soluble
SMILES CC(C)(N1CCOCC1)C(=O)N[C@H]1COC[C@H]1Cc1ccnc2ccccc12 |r|
Best offer
$100.00
Including direct shipping

Pack size:
5 micromol
Shipping to:
United States
Lead time:
21 business days
Adjust Requirements

ChemBridge Corporation

Direct S&H to USA
45.00 USD
Catalog
Screening compound
Ships out
21 business days
Purity
85%
Last updated
last week
In warehouse
5.00 mg
Salt: FREE

Supplier Catalogue Data

Pack size
Ships out
Price
Quantity
5 micromol
January 9, 2023
55.00 USD
1 mg
January 9, 2023
45.00 USD
5 mg
January 9, 2023
65.00 USD
Simpler, smarter compound sourcing with Molport
  • Extensive vetted supplier network
  • Smart standardised systems and intelligent fulfilment
  • Experienced support and expert lab services
We supply companies including
Fraunhofer logo Domainex logo Reverie labs logo
Search and order chemical compounds instantly
View search options
Access and search our databases offline
Access databases

More Information

Compound identifiers

Compound number
MolPort-046-520-015

Names, Synonyms and 3rd Party Identifiers

2-methyl-2-(4-morpholinyl)-N-[cis-4-(4-quinolinylmethyl)tetrahydro-3-furanyl]propanamide

InChI

InChI
1/C22H29N3O3/c1-22(2,25-9-11-27-12-10-25)21(26)24-20-15-28-14-17(20)13-16-7-8-23-19-6-4-3-5-18(16)19/h3-8,17,20H,9-15H2,1-2H3,(H,24,26)/t17-,20+/m1/s1
InChI key
XYKZLKGFQDNCDD-XLIONFOSSA-N

Formula

Molecular formula
C22H29N3O3
Molecular weight
383.492

Molport Guarantee

When you purchase products through the Molport website from any seller other than Molport itself, you will be protected by the Molport Guarantee. If you purchase products from Molport itself, this Molport Guarantee will not apply, and your remedies will be governed by the Molport Terms of Sale and Supply.

We use cookies to improve your experience on our websites and for advertising. By clicking "Accept All", you consent to our use of cookies. Learn more.

Feedback